echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Biochemistry News > Biotechnology News > The Tibetan Medicine Standardization and New Drug R&D discipline group made a new breakthrough in the screening strategy of countercurrent chromatography solvent system

    The Tibetan Medicine Standardization and New Drug R&D discipline group made a new breakthrough in the screening strategy of countercurrent chromatography solvent system

    • Last Update: 2022-12-30
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com
      

    Counter-current chromatography (CCC) is a liquid-liquid chromatography technology, compared with the traditional liquid preparative chromatography technology, it has the advantages of no fixed phase death adsorption and 100% sample recovery, and is widely used
    in separation science.
    The selection of a solvent system based on the partition coefficient (K) is the most important step in CCC separation, and the optimization of solvent system selection accounts for up
    to 90% of the workload in CCC separation.
    At present, the selection and optimization of solvent system based on HPLC peak area trial and error method is the most commonly used method, which is time-consuming and labor-intensive, which limits the more in-depth and extensive application
    of CCC in separation science.

    Recently, the Tibetan Medicine Standardization and New Drug R&D Group of the Northwest Institute of Plateau Biology, Chinese Academy of Sciences, in collaboration with Qinghai Normal University and Jinan University, published a report entitled Ab initio calculation based solvent system selection in silico for counter-current in the Journal of Chromatography A (IF=4.
    6).
    Research paper
    on chromatography: Separation of resibufogenin glycosylation product 。 This paper establishes a selection optimization strategy for ab initio calculation of CCC solvent system based on thermodynamic calculation and limiting optimization, which includes three steps: 1) the COSMO-RS model is used to calculate the partition coefficient of the given solvent system from scratch; 2) Using (non)linear fitting, establish a functional relationship between the ab initio calculation of the partition coefficient and the composition ratio of the given solvent system; 3) Using MATLAB, 0.
    5 ≤ Ki ≤2.
    5 and Ki/Kj≥1.
    5 (Ki>Kj) are used as the boundary conditions, and minΣ (Ki) is used as the objective function for restriction optimization, so as to optimize and select a suitable solvent system
    。 In order to verify the feasibility of the strategy in practical application, taking the glycosylation product of the ester toad toxicity ligand as the separation target, without any experimental operation data, the optimal solvent system was successfully optimized by this strategy, and the CCC separation and preparation of the target compound was well completed, and the optimized partition coefficient was calculated ab novo compared with the measured value of the posterior experiment
    。 This strategy can almost 100% completely optimize the selection and optimization of CCC solvent system in the computer, without any experimental data, which greatly reduces the workload of solvent system selection optimization, improves the separation efficiency of CCC, and greatly promotes the wide and in-depth application
    of CCC in conventional separation science.

    Chen Tao, associate researcher of Northwest Plateau Institute, is the first author of this paper, Li Yulin, researcher of Northwest Plateau Institute, associate professor He Liangliang of Jinan University and associate professor Zou Denglang of Qinghai Normal University are co-corresponding authors
    of the paper.
    This work was supported by the National Natural Science Foundation of China (No.
    32260129), Youth Promotion Association of Chinese Academy of Sciences (No.
    2020425) and Qinghai Provincial Natural Science Foundation (No.
    2021-ZJ-976Q).

    Link to paper:

    Research technology roadmaps

     

    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.